| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:3043-3048.)
© 2004 American Heart Association, Inc.
Congenital Heart Disease |
From the Fetal Cardiology Unit, Cardiology Division, Departments of Pediatrics (M.J.R., J.C.F., J.L., F.P., S.G.), Obstetrics (L.L.), and Radiology (A.G.), St. Justine Hospital, Université de Montréal, Montreal, Quebec, Canada.
Reprint requests to Jean-Claude Fouron, MD, St. Justine Hospital, Cardiology Service , 3175, Côte Ste-Catherine, Montréal, Québec H3T 1C5, Canada. E-mail fouron{at}sympatico.ca
Received March 29, 2004; revision received June 25, 2004; accepted July 1, 2004.
| Abstract |
|---|
|
|
|---|
Methods and Results Eight variables were analyzed on the first fetal echocardiography on 21 pairs of twins with TTTS and 11 with IUGR. No difference was found between the 2 groups for the cardiothoracic ratio, pulsatility indices in the umbilical and middle cerebral arteries, and peak velocity of the middle cerebral artery. Significant difference was found for ventricular septal thickness, but with no association with the conditions under study. With TTTS, left ventricular shortening fraction was consistently greater in the donor twins, and myocardial performance indices (MPIs) were elevated in the recipient twins. This increase in MPI was caused by a lengthening of the isovolumic periods compared with those of the donor twin: left ventricular and right ventricular isovolumic periods 0.105±0.047 and 0.097±0.026 seconds, respectively, for the recipient twins versus 0.0561±0.46 and 0.065±0.03 seconds, respectively, for the donor twins (P<0.001). These changes in the isovolumic periods were mainly due to significant prolongation of isovolumic relaxation times. A change in left ventricular MPI
0.09 combined with a change in right ventricular MPI
0.05 would identify a TTTS with a sensitivity of 75% and a false-positive rate of 9%.
Conclusions The observed diastolic function impairment goes along with the pressure-overload pathogenic concept proposed in TTTS. Assessment of intertwin difference in MPI is a valuable tool for early differential diagnosis between TTTS and isolated IUGR.
Key Words: fetofetal transfusion myocardium cardiomyopathy diastole
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Monochorionicity was identified by the presence of twins of the same sex with a single placenta and echographic evidence of a thin (<2 mm) amniotic membrane. This was confirmed after birth by pathological examination of the placenta. The diagnosis of TTTS was first suspected because of difference in fetal growth (ratio between the 2 abdominal circumferences <0.93), the development of an oligopolyhydramnios sequence (deepest pool >8 cm for the larger amniotic sac and <1 cm for the smaller one), and progressive appearance of cardiomyopathy in the recipient twin. Placental insufficiency was considered when the dimensions of the smaller fetus were below the 10th percentile,13 with a pulsatility index of the umbilical artery (PIUA) rising above the 95th percentile14 during the course of the pregnancy. In this case, the ultrasonographic appearance of the bigger fetus was normal. Fetal weight and gestational age were determined by the earliest second-trimester ultrasound measurements of head and abdominal circumferences and femur length.15,16 The severity of the TTTS at the time of the first echocardiography was assessed according to criteria proposed by Quintero et al17: stage I, isolated oligopolyhydramnios sequence; stage II, absent visible bladder in the donor; stage III, absent/reversed end-diastolic arterial flow of the umbilical artery or reversal of flow during atrial contraction in ductus venosus; and stage IV, hydrops in either fetus.
Ultrasound Studies
Cardiocirculatory investigations were performed with a 128 XP/10c or Sequoia sonographic equipment from Acuson with either a 5 or a 6 C2 MHz transducer. Studies were recorded on videotape for further analysis. The following parameters were routinely measured in all fetuses according to techniques described previously: cardiothoracic ratio,18 PIUA,14 the pulsatility index (PI) and peak systolic velocity of the middle cerebral artery (MCA),19 left ventricular shortening fraction (LVSF), and end-diastolic interventricular septal thickness (IVST).20 Ventricular myocardial performance index (MPI), defined as the isovolumetric period (sum of isovolumetric contraction and relaxation times) divided by the ventricular ejection time,21 was also measured. Pulsed Doppler waveforms recorded above the pulmonary and aortic valves and at the tip of the tricuspid and mitral valves were used for right ventricular (RVMPI) and left ventricular (LVMPI) MPI measurements, respectively. The isovolumetric period was obtained by subtracting the ventricular ejection time from the period between cessation and onset of the AV valve inflow signal (top of Figure 1). In addition, isovolumetric contraction and relaxation times were measured on transmitral and ventricular ejection Doppler waveforms recorded on the same tracing by placing the Doppler sample volume in the left ventricular (LV) outlet chamber, as described previously.22 Doppler echographic signals of closure and opening of the mitral valve and the brief marker of aortic closure could be recorded on the same tracing, as shown at the bottom of Figure 1. The duration of the cardiac cycle that preceded each waveform was also noted for heart rate calculation. The data represent the average of 3 consecutive measurements.
|
Statistical Analysis
The data were analyzed in 2 steps. First, ANOVAs were done to identify significant predictors of TTTS. Differences between the 2 conditions (TTTS and IUGR) were evaluated by an ANOVA with 1 between-subjects factor (condition) and 2 within-subject factors (variables measured and twins). Owing to sample size discrepancies between the 2 groups, the Pilais trace multivariate test was used because it is more robust in this case.23 It was believed that there would be significant interactions between the factors; therefore, the full factorial model was planned to identify the presence of statistically significant interactions. In case of significant interaction between factors, appropriate subanalyses were planned. Probability values of less than 0.05 were considered significant, except for the Levene test of equality of variances, which was considered significant if P<0.001. All analyses were done with the SPSS system version 11.5. In the second part of the analyses, diagnostic characteristics were computed for the relevant variables. Receiver operating characteristic curves and probability tables were constructed that expressed the sensitivity, specificity, and false-positive rate of various levels of intertwin differences, with the objective of finding the difference values at which the diagnosis of TTTS could be established with confidence.
| Results |
|---|
|
|
|---|
Table 1 gives means and SDs for all cardiocirculatory variables obtained in both groups during the first echocardiographic study, as well as for intertwin differences. Initial statistics indicated that the cardiothoracic ratio did not meet the prerequisites to be analyzed along with the other measures (Levene test of equality of variances P<0.001). The first repeated-measures ANOVA indicated that all 2-way interactions between the 7 variables analyzed, the twin babies, and the condition were significant. Seven subanalyses (for each measure taken individually) were therefore undertaken. The variables PIUA (P=0.158), PI of the MCA (P=0.672), and peak systolic velocity of the MCA (P=0.079) did not show significant associations with the condition group. It follows that they could not be used as diagnostic tools to differentiate between the 2 conditions. The variable IVST showed significant differences between the twins (P<0.001) in general, but no significant association was found with the condition group (P=0.569). The analysis of the other 3 variables (LVSF, LVMPI, and RVMPI) indicated a significant 2-way interaction between the twin and the condition factors. The type of interaction indicated that it was appropriate to analyze those variables through independent group t tests on intertwin differences for each of those 3 variables. Intertwin differences were all significantly associated with the condition and could therefore be used to distinguish the 2 groups. The intertwin differences (large minus small) for LVSF (
LVSF) were positive for IUGR (1.964±4.617) and negative for TTTS (8.205±9.833). The divergence between those 2 differences was statistically significant (P=0.003). The intertwin differences for RVMPI (
RVMPI) were significantly smaller (P=0.015) for IUGR (0.011±0.074) than for TTTS (0.176±0.193). Finally, the differences between large and small babies for LVMPI (
LVMPI) were significantly smaller (P<0.001) for IUGR (0.023±0.100) than for TTTS (0.262±0.176). The elevated MPIs observed in the recipient twins were caused by a lengthening of the isovolumic periods (LV isovolumic period 0.105±0.047, right ventricular [RV] isovolumic period 0.097±0.026 seconds) compared with the donor twin (LV isovolumic period 0.0561±0.046, RV isovolumic period 0.065±0.03 seconds; P<0.001). The ejection times were essentially the same in both groups of twins (for the recipient: LV ejection time 0.175±0.017, RV ejection time 0.178±0.015; for the donor: LV ejection time 0.177±0.015, RV ejection time 0.172±0.017; P=0.744 and 0.115, respectively). As illustrated in Figure 2, these changes in isovolumic period were mainly due to a significant prolongation of the isovolumic relaxation times.
|
|
Receiver operating characteristic curves were done for the intertwin differences between LVSF and MPIs. The areas under the curve were statistically significant for
LVSF (area=0.810, P=0.009),
RVMPI (area=0.842, P=0.004), and
LVMPI (0.865, P=0.002). Table 2 presents the sensitivity and specificity of various differences in those 3 variables for the early diagnosis of TTTS as opposed to IUGR. The results reveal that a cutoff value of 0.09 for
LVMPI could identify twins with TTTS with a sensitivity of 79% and a false-positive rate of 33%. A cutoff value of 0.05 for the
RVMPI has a sensitivity of 82% and a false-positive rate of 32%. Finally, a cutoff value of 0 for
LVSF has a sensitivity of 79% and a false-positive rate of 33%. Moreover, if we were to diagnose TTTS for any pair of twins that showed at least 1 of those characteristics, the sensitivity of this diagnosis would be 100%, and the false-positive rate would be 64%. This means that 64% of twins without TTTS show at least 1 of those 3 characteristics. If we were to predict TTTS for any pair of twins that showed any combination of 2 of those intertwin differences, the sensitivity of this diagnostic would be 90%, and the false-positive rate would be 18%. An examination of all specific combinations revealed that if we were to diagnose TTTS only for pairs of twins whose 2 criteria were specifically
LVMPI of 0.09 and
RVMPI of 0.05, the sensitivity of the diagnosis would be 75%, and the false-positive rate would be 9%. Any other combination of 2 specific criteria would have lower predictive power (lower sensitivity and higher false-positive rate). Finally, if we were to predict TTTS for only pairs of twins that showed all of those characteristics concomitantly, the sensitivity of this diagnostic would be 50%, and the false-positive rate would be 9%.
|
| Discussion |
|---|
|
|
|---|
This observation goes along with the concept that the pathogenesis of the cardiomyopathy described in TTTS is not related to a simple transfer of blood volume or hemoglobin from 1 twin to the other. Reports that the severity of the syndrome does not always correlate with intertwin differences in hemoglobin27 or erythropoietin28 support this proposition. The alternate hypothesis is that cardiac dysfunction in the recipient twin results from raised afterload due to increased systemic resistance and pressure.11 The renin-angiotensin system has been shown to be upregulated in donor twins and downregulated in recipient twins.29 This potentially beneficial adaptive mechanism against hypovolemia in the donor could become deleterious to the co-twin, however, owing to transfer of effectors such as angiotensin II through placental shunts, inducing a cardiomyopathy both by direct effect on the myocytes30 and by peripheral vasoconstriction that leads to elevated afterload.31,32 Concentrations of endothelin, a potent vasoconstrictor, have also been found to be 2.5 times higher in recipient twins than in their co-twins.10 Experimental33 and clinical34 investigations suggest that endothelin and angiotensin could induce pressure-overload cardiac hypertrophy through a common pathway. The present data show that this cardiac hypertrophy, demonstrated by increased IVST, is an early finding during the development of TTTS. In contrast with postnatal life, increase in fetal systemic afterload results in biventricular myocardial hypertrophy because of the parallel disposition of the 2 ventricles. In rare cases, this hypertrophy could lead to severe acquired RV outflow tract obstruction.35
The results of the probability studies show that various levels of differences between the recipient and donor twins for LVMPIs and LVSF could identify twins with TTTS with a sensitivity between 80% and 90% but a relatively poor specificity. TTTS could be diagnosed, however, with a sensitivity of 75% and a false-positive rate of 9% when a combination of the following 2 cutoff values is applied:
LVMPI 0.09 and
RVMPI 0.05. The addition of the
LVSF to this combination decreases the sensitivity to 50%. In a previous investigation, the LVSF of donor and recipient twins was also found to be significantly different during the evolution of TTTS.36 The present study confirms that this difference occurs early and is due to a higher shortening fraction in the donor, with the recipient being normal. Compared with MPI, the measurement of fetal shortening fraction is challenging, requiring a perpendicular approach to the ventricular free walls, and consequently, it shows poorer repeatability than the Doppler technique.37 This could explain the loss of sensitivity observed when LVSF was added to the combination of the 2 ventricular MPIs.
Because a significant difference was found between IVST of twins in both groups, this variable is of little help in the differential diagnosis process. Similarly, as reported previously, Doppler investigation of the umbilical artery was not contributive38; as could be expected, a greater value was observed for the PIUA of the smaller fetus with placental circulatory insufficiency, but the difference was not yet significant at this early stage of the disease. Higher peak velocity has been reported in the MCA of the smaller twin in TTTS,39 which reflects circulatory adjustment to anemia. No differences were found in any of our 2 groups of twins for either the PI or the peak velocity of the MCA. This could be related to a lesser severity of anemia at this early stage of the TTTS.
In conclusion, increased myocardial systolic performance of the donor twin and impairment of diastolic function of the recipient are observed early in TTTS. This diastolic impairment strengthens the pressure-overload concept in the pathogenesis of the hypertrophic cardiomyopathy observed in the recipient twin. Assessment of intertwin differences of ventricular MPIs appears to be a valuable tool for early differential diagnosis between TTTS and isolated IUGR.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2. Fraser D, Picard R, Picard E, et al. Birth weight discordance, intrauterine growth retardation and perinatal outcomes in twins. J Reprod Med. 1994; 39: 504508.[Medline] [Order article via Infotrieve]
3. Fesslova V, Villa L, Nava S, et al. Fetal and neonatal echocardiographic findings in twin-twin transfusion syndrome. Am J Obstet Gynecol. 1998; 179: 10561062.[CrossRef][Medline] [Order article via Infotrieve]
4. Simpson LL, Marx GR, Elkatry EA, et al. Cardiac dysfunction in twin-twin transfusion syndrome: a prospective longitudinal study. Obstet Gynecol. 1998; 92: 557562.[CrossRef][Medline] [Order article via Infotrieve]
5. Cheung YF, Taylor MJO, Fisk NM, et al. Fetal origins of reduced arterial distensibility in the donor twin in twin-twin transfusion syndrome. Lancet. 2000; 355: 11571158.[CrossRef][Medline] [Order article via Infotrieve]
6. Pinette MG, Pan Y, Pinette SG, et al. Treatment of twin-twin transfusion syndrome. Obstet Gynecol. 1993; 82: 841846.[Medline] [Order article via Infotrieve]
7. Van Gemert MJ, Major AL, Scherjon SA. Placental anatomy, fetal demise and therapeutic intervention in monochorionic twins and the transfusion syndrome: new hypotheses. Eur J Obstet Gynecol Reprod Biol. 1998; 78: 5362.[CrossRef][Medline] [Order article via Infotrieve]
8. De Lia JE, Kuhlmann RS, Lopez KP. Treating previable twin-twin transfusion syndrome with fetoscopic laser surgery: outcomes following the learning curve. J Perinat Med. 1999; 27: 617.[CrossRef][Medline] [Order article via Infotrieve]
9. Gardiner HM, Taylor MJO, Karatza A, et al. Twin-twin transfusion syndrome: the influence of intrauterine laser photocoagulation on arterial distensibility in childhood. Circulation. 2003; 107: 19061911.
10. Bajoria R, Sullivan M, Fisk NM. Endothelin in association with cardiac dysfunction in the recipient fetus to twin-twin transfusion syndrome. Hum Reprod. 1999; 14: 16141618.
11. Mahieu-Caputo D, Muller F, Joly D, et al. Pathogenesis of twin-twin transfusion syndrome: the renin-angiotensin system hypothesis. Fetal Diagn Ther. 2000; 16: 241244.[CrossRef]
12. Karatza AA, Wolfenden JL, Taylor MJO, et al. Influence of twin-twin transfusion syndrome on fetal cardiovascular structure and function: prospective case-control study of 136 monochorionic twin pregnancies. Heart. 2002; 88: 271277.
13. Arbuckle TE, Wilkins R, Sherman GJ. Birth weight percentiles by gestational age in Canada. Obstet Gynecol. 1993; 81: 3948.[Medline] [Order article via Infotrieve]
14. Sonesson SE, Fouron JC, Drblik SP, et al. Reference values for Doppler velocimetric indices from the fetal and placental ends of the umbilical artery during normal pregnancy. J Clin Ultrasound. 1993; 21: 317324.[Medline] [Order article via Infotrieve]
15. Shepard MJ, Richards VA, Berkowitz RL, et al. An evaluation of two equations for predicting fetal weight by ultrasound. Am J Obstet Gynecol. 1982; 1: 4754.
16. Hadlock FP, Harrist RB, Carpenter RJ, et al. Sonographic estimation of fetal weight: the value of femur length in addition to head and abdomen measurements. Radiology. 1984; 150: 535540.
17. Quintero RA, Morales WJ, Allen MH, et al. Staging of twin-twin transfusion syndrome. J Perinat. 1999; 19: 550555.[CrossRef]
18. Paladini D, Chita SK, Allan LD. Prenatal measurement of cardiothoracic ratio in evaluation of heart disease. Arch Dis Child. 1990; 65: 2023.
19. Mari G, Deter RL. Middle cerebral artery flow velocity waveforms in normal and small for gestational age fetuses. Am J Obstet Gynecol. 1992; 166: 12621270.[Medline] [Order article via Infotrieve]
20. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 2: 358367.[Medline] [Order article via Infotrieve]
21. Tei C, Nishimura RA, Seward JB, et al. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous cardiac catheterization measurements. J Am Soc Echocardiogr. 1997; 10: 169178.[CrossRef][Medline] [Order article via Infotrieve]
22. Raboisson MJ, Bourdages M, Fouron JC. Measuring the left ventricular myocardial performance index in fetuses. Am J Cardiol. 2003; 91: 919921.[CrossRef][Medline] [Order article via Infotrieve]
23. Tabachnick BG, Fidell LS. Profile analysis: the multivariate approach to repeated measures. In: Using Multivariate Statistics. 4th ed. Boston, Mass: Allyn & Bacon; 2001: 391455.
24. Eidem BW, Edwards JM, Cetta F. Quantitative assessment of fetal ventricular function: establishing normal values of the myocardial performance index in the fetus. Echocardiography. 2001; 18: 913.[Medline] [Order article via Infotrieve]
25. Mori Y, Rice MJ, McDonald RW, et al. Evaluation of systolic and diastolic ventricular performance of the right ventricle in fetuses with ductal constriction using the Doppler Tei index. Am J Cardiol. 2001; 88: 11731178.[CrossRef][Medline] [Order article via Infotrieve]
26. Falkensammer CB, Paul J, Huhta JC. Fetal congestive heart failure: correlation of Tei-index and cardiovascular-score. J Perinat Med. 2001; 29: 390398.[CrossRef][Medline] [Order article via Infotrieve]
27. Saunders NJ, Snijders RJ, Nicolaides KH. Twin-twin transfusion syndrome during the second trimester is associated with small intertwin hemoglobin differences. Fetal Diagn Ther. 1991; 6: 3436.[Medline] [Order article via Infotrieve]
28. Bajoria R, Ward S, Sooranna SR. Erythropoietin in monochorionic twin pregnancies in relation to twin-twin transfusion syndrome. Hum Reprod. 2001; 16: 574580.
29. Mahieu-Caputo D, Dommerjues M, Delezoide AL, et al. Twin-to-twin transfusion syndrome: role of the fetal renin-angiotensin system. Am J Pathol. 2000; 156: 629636.
30. Baker KM, Brooz GW, Dostal DE. Cardiac actions of angiotensin-II: role of an intra-cardiac renin angiotensin system (review). Annu Rev Physiol. 1992; 54: 227241.[CrossRef][Medline] [Order article via Infotrieve]
31. Bajoria R, Sooranna SR. Elevated renin-angiotensin levels in the recipient twin of severe twin-twin transfusion syndrome with a neonatal hypertension. Placenta. 1999; 20: A13. Abstract.[CrossRef]
32. Baud O, Lebidois J, Van Peborgh P. Fetal and neonatal hypertension in twin-twin transfusion syndrome: a case report. Fetal Diagn Ther. 1998; 13: 223226.[CrossRef][Medline] [Order article via Infotrieve]
33. Ito H, Hiroe M, Hirata Y, et al. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation. 1994; 89: 21982203.
34. Wei CM, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive heart failure. Circulation. 1994; 89: 15801586.
35. Lougheed J, Sinclair BG, Fung K. Acquired right ventricular outflow tract obstruction in the recipient twin in twin-twin transfusion syndrome. J Am Coll Cardiol. 2001; 1: 15331538.
36. Lachapelle MF, Leduc L, Côté JM. Potential value of fetal echocardiography in the differential diagnosis of twin pregnancy with presence of polyhydramnios-oligohydramnios syndrome. Am J Obstet Gynecol. 1997; 177: 388394.[CrossRef][Medline] [Order article via Infotrieve]
37. Simpson JM, Cook A. Repeatability of echocardiographic measurements in the human fetus. Ultrasound Obstet Gynecol. 2002; 20: 332339.[CrossRef][Medline] [Order article via Infotrieve]
38. Gaziano EP, Knox E, Bendel RP. Is pulsed Doppler velocimetry useful in the management of multiple gestation pregnancies? Am J Obstet Gynecol. 1991; 164: 14261431.[Medline] [Order article via Infotrieve]
39. Suzuqui S, Sawa R, Yoneyama Y. Fetal middle cerebral artery Doppler waveforms in twin-twin transfusion syndrome. Gynecol Obstet Invest. 1999; 48: 237240.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
J. D. Pruetz, R. H. Chmait, and M. S. Sklansky Complete Right Heart Flow Reversal: Pathognomonic Recipient Twin Circular Shunt in Twin-Twin Transfusion Syndrome J. Ultrasound Med., August 1, 2009; 28(8): 1101 - 1106. [Full Text] [PDF] |
||||
![]() |
N. E. Russell and F. M. McAuliffe First-Trimester Fetal Cardiac Function J. Ultrasound Med., March 1, 2008; 27(3): 379 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Acharya, J. Rasanen, K. Makikallio, T. Erkinaro, T. Kavasmaa, M. Haapsamo, L. Mertens, and J. C. Huhta Metabolic acidosis decreases fetal myocardial isovolumic velocities in a chronic sheep model of increased placental vascular resistance Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H498 - H504. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |